Shares of Thermo Fisher Scientific Inc. TMO shed 1.04% to $528.87 Wednesday, on what proved to be an all-around great trading ...

Thermo Fisher's patent activity and acquisition strategy support growth. Find out why TMO stock is poised for continued ...

As the global energy landscape evolves towards renewable sources, electric utilities and power plant operators are ...

The murder of UnitedHealthcare chief executive Brian Thompson in Manhattan on Wednesday has raised questions about security ...

Thermo Fisher Scientific (NYSE:TMO) has completed the repurchase of $1B (1.9M shares) of its common stock. As of Dec. 3, 2024, $3B remained available under the company’s share repurchase authorization ...

Thermo Fisher (TMO) announced that it has completed the repurchase of $1B of its common stock. As of December 3, $3B remained available under ...

Mainz Biomed partners with Thermo Fisher to develop advanced colorectal cancer screening tools while enhancing ColoAlert for ...

Health care stocks have underperformed in recent months on uncertainty surrounding the incoming Donald Trump administration, but they can often be a solid defensive play in an uncertain economy.

The training is free to participants thanks to funding support from the Louisiana Biomedical Research Network through an Institutional Development Award (IDeA) from the National Institute of General ...

Billionaire Ken Fisher is dramatically increasing his firm's position in US banking giant JPMorgan Chase. New SEC filings ...

The global cell culture media market is expected to grow from USD 3,513.8 million in 2024 to USD 6,699.93 million by 2034, at ...